Bristol students aim to tackle skin colour disparity in skin cancer care
UK doctors are far more likely to misdiagnose skin cancers in those with black or brown skin
Last updated 13th Apr 2024
Three medical students from the University of Bristol are hoping to solve the shocking disparity in skin cancer care between those with dark skin and those with white skin.
Stunned to learn that UK doctors were far more likely to misdiagnose skin cancers in those with black or brown skin, students Mariana Wickramarachchi, Harvey Hill and Elizabeth Maregere decided to act.
Their start-up DermSpectrum is building the UK’s most diverse and advanced skin image bank, to teach students and clinicians how to diagnose skin conditions regardless of colour.
In the US, 5-year skin cancer survival rates are 70% for black people and 92% for white people. In the UK, equivalent studies are not widely available – but a study of GPs found they were much more likely to misdiagnose melanomas in dark skin.
The students hope that improving early diagnosis of skin cancer in black and brown people will save lives, improve equality and lighten the load on the NHS.
After surveying students at UK medical schools, they found trainee doctors were nearly twice as confident at diagnosing conditions on white skin compared to skin of colour.
Harvey said: “It’s shocking seeing the underrepresentation in the UK curriculum. We went through one of the most widely used medical textbooks in the UK, with 1.5million copies sold. Out of the 600 diagrams and images of patients, we could only find fewer than 10 images of patients with black or brown skin.
“Medical students are the starting point. We want this to be a resource for students and then we want to roll it out to the rest of the medical community from there.”
Improving diagnosis is not just a moral action but also financial. Healthcare costs for those diagnosed with Stage IV melanoma are reported to be between 25 and 52 times higher than for those diagnosed at Stage IA.
The cost of diagnosing and treating skin cancer in the UK is estimated to rise to between £338 and £465 million a year by 2025.
Elizabeth said: “Misdiagnosis or missed diagnosis, due to inadequate representation, can have massive repercussions on patients. We want to increase diversity within medical education to reduce inequality, for black and brown people.”